Press Releases

Press Releases

July 18, 2017
Dr. Daniel Sikkema joins Quanterix as Vice President of Accelerator Services to lead the growth of the company’s contract research lab and support precision health advances across a wide range of therapeutic categories
July 6, 2017
Breakthrough Research Published in PLOS ONE Demonstrates Quantitative, PCR-Free Detection of MicroRNA
June 26, 2017
Kevin Hrusovsky, Executive Chairman and CEO of Quanterix is a finalist for the Entrepreneur Of The Year® 2017 Award in the New England program. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and…
June 22, 2017
CEO and Chairman, Kevin Hrusovsky, will be hosting a webinar on the use of ultrasensitive biomarker assays to enable precision health, with a specialty focus on concussion and traumatic brain injury (TBI) detection and diagnostics.  Hrusovsky will be joined by Dr. Jessica Gill, Investigator at…
May 17, 2017
New panel offers unmatched sensitivity to simultaneously measure four proven neurological protein biomarkers in blood and cerebrospinal fluid within a single test
May 16, 2017
CEO to discuss promising role of protein biomarkers in advancing detection and treatment of traumatic brain injury
May 9, 2017
Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced that Smithers Avanza , a contract research organization supporting the pharmaceutical industry, is adding the Simoa HD-1 Analyzer to its Bioanalytical Laboratory. With this…
May 1, 2017
Kevin Hrusovsky, CEO and Executive Chairman at Quanterix, will join a distinguished panel of industry experts to discuss the state and future of precision cardiovascular medicine at the World Medical Innovation Forum. The panel is taking place Tuesday, May 2nd, from 2:00-2:50pm.
Discussion to be led by Cedars-Sinai Medical Center Professor of Medicine Dr. Jennifer E. Van Eyk
Quanterix is sponsoring a webinar by Dr. Jennifer E. Van Eyk, professor of medicine, Cedars-Sinai Medical Center, on the need for precise protein quantification and identification in personalized medicine on Tuesday, April 18, 2017 from 1:00 – 2:00 p.m. EST.
February 3, 2017
HOUSTON and LEXINGTON, Mass.—February 3, 2017—Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced that Kevin Hrusovsky, Quanterix Chief Executive Office